Rheumatoid arthritis Initial PBS authority application and Supporting information form (PB109)

This form must be completed by a rheumatologist or clinical immunologist with expertise in the management of rheumatoid arthritis. You must lodge this form for an adult patient starting initial PBS subsidised treatment with a biological Disease Modifying Anti Rheumatic Drug (bDMARD), excluding rituximab, recommencing PBS subsidised bDMARD treatment where they have failed fewer than 5 bDMARDs, for which they are eligible, and where the break in treatment is longer than 24 months.

 

Page last updated: 5 February 2016

This information was printed Sunday 25 September 2016 from humanservices.gov.au/health-professionals/forms/pb109 It may not include all of the relevant information on this topic. Please consider any relevant site notices at humanservices.gov.au/siteinformation when using this material.